薄层黑色素瘤的死亡负担与预后:SEER登记数据1992-2013
该研究基于SEER 13登记处1992-2013年数据,分析49,319例1992-2003年诊断的I-II期黑色素瘤,按T1-T4及T1亚层细分,评估10年内黑色素瘤死亡例数与比例。结果显示预后随厚度增加而恶化,但多数死亡来自T1期诊断的黑色素瘤,且T1内0.01-0.25mm亚组的10年死亡风险高于0.26-0.50mm亚组,从0.51mm起预后变差,此模式不能用溃疡解释。结论强调薄层黑色素瘤是重要公共卫生负担,应努力在原位阶段诊断。
要点
- 多数黑色素瘤死亡来自T1期诊断的薄层黑色素瘤。
- T1内0.01-0.25mm亚组的10年死亡风险高于0.26-0.50mm亚组。
- 从0.51mm起预后随厚度增加而恶化,溃疡不能解释T1内模式。
核心结论
- 薄层黑色素瘤导致大量死亡,是重要公共卫生负担。
- 应努力在黑色素瘤原位阶段进行诊断。
研究设计与样本
- 基于SEER 13登记处1992-2013年数据,纳入49,319例1992-2003年诊断的I-II期黑色素瘤。
- 按T1-T4分期,并将T1细分为0.01-0.25mm、0.26-0.50mm、0.51-0.75mm和0.76-1.00mm亚组,分析10年内黑色素瘤死亡例数与比例。
主要发现
- 预后随黑色素瘤厚度从T1到T4增加而恶化。
- 多数死亡由T1期诊断的黑色素瘤导致。
- T1内0.01-0.25mm亚组的10年死亡风险高于0.26-0.50mm亚组。
- 从0.51mm起预后变差,T1内模式不能用溃疡解释。
关键数值与推荐
- T1亚组厚度划分:0.01-0.25mm、0.26-0.50mm、0.51-0.75mm、0.76-1.00mm。
- 评估指标为诊断后10年内黑色素瘤死亡例数与比例。
临床怎么用
- 临床应重视薄层黑色素瘤的死亡风险,尤其T1期病变。
- 努力在黑色素瘤原位阶段进行诊断以降低死亡负担。
局限性
- 未评估黑色素瘤亚型、核分裂率或其他相关特征。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Thin melanomas cause a high death toll despite excellent prognosis. OBJECTIVE: We examined melanoma mortality burden and prognosis by categories of thickness within Surveillance, Epidemiology, and End Results (SEER) 13 Registry 1992-2013. METHODS: We divided 49,319 stage I and II melanoma cases diagnosed between 1992 and 2003 into T1 through T4 and then subdivided T1 into 0.01-0.25 mm, 0.26-0.50 mm, 0.51-0.75 mm, and 0.76-1.00 mm categories. We determined the number and proportion of deaths due to melanoma within 10 years of diagnosis for each thickness category and proportions within T1 subcategories with ulceration. RESULTS: We confirmed prognosis worsened as melanoma thickened from T1 to T4; however, most deaths resulted from melanomas that were diagnosed at the T1 stage. The smallest number of deaths within T1 resulted from 0.01-0.25 mm-thick melanomas; however, the risk for death within 10 years was greater for those diagnosed with melanoma when tumor depth was 0.01-0.25 mm than for those diagnosed when tumor depth was 0.26-0.50 mm. Prognosis worsened with depths starting at 0.51 mm. The pattern within T1 was not explained by ulceration. LIMITATIONS: We did not evaluate melanoma subtype, mitotic rate, or other associated features. CONCLUSION: Thin melanomas are a substantial public health burden. Efforts should be made to diagnose melanoma at the in situ stage.
引用
- Landow SM, Gjelsvik A, Weinstock MA, et al. Mortality burden and prognosis of thin melanomas overall and by subcategory of thickness, SEER registry data, 1992-2013. J Am Acad Dermatol. 2016. PMID: 27887797. doi:10.1016/j.jaad.2016.10.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。